Henry ScheinHSIC +2.27%80 Return-on-Tangible-Equity is Negative Tangible Equity% as of Mar. 2026. GuruFocus rates HSIC with a GF Score™ of 80/100 and a GF Value™ of $83.72 (Fairly Valued). The stock has 8 warning signs investors should review. Among 111 Medical Distribution companies, Henry Schein ranks better than 99.1% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Henry Schein's annualized net income for the quarter that ended in Mar. 2026 was $428 Mil. Henry Schein's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $-2,006 Mil. Therefore, Henry Schein's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was Negative Tangible Equity%.
The historical rank and industry rank for Henry Schein's Return-on-Tangible-Equity or its related term are showing as below:
HSIC'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 190.74 Med: 297.94 Max: 472.04
Current: Negative Tangible Equity
During the past 13 years, Henry Schein's highest Return-on-Tangible-Equity was 472.04%. The lowest was 190.74%. And the median was 297.94%.
HSIC's Return-on-Tangible-Equity is ranked better than 99.1% of 111
companies
in the Medical Distribution industry
Industry Median: 8.81
vs HSIC: Negative Tangible Equity
Henry Schein (NAS:HSIC) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Henry Schein Return-on-Tangible-Equity Related Terms
Henry Schein Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Henry Schein's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HSIC vs AHG, ACH, FOCL: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, Henry Schein's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henry Schein Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Henry Schein's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Henry Schein's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of Negative Tangible Equity% mean?
Henry Schein (HSIC) has a Return-on-Tangible-Equity of Negative Tangible Equity% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Henry Schein and its competitors. Over the past decade, Henry Schein's Return-on-Tangible-Equity has ranged from 190.74 to 472.04. According to the industry distribution chart, Henry Schein ranks #1 out of 111 companies in the Medical Distribution industry, placing it in the top 0.90000000000001%.
Is Henry Schein's Return-on-Tangible-Equity too high?
Henry Schein's current Return-on-Tangible-Equity is Negative Tangible Equity%. Over the past 10 years, this metric has ranged from a low of 190.74 to a high of 472.04. Based on the distribution chart, Henry Schein ranks #1 out of 111 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Henry Schein has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henry Schein's Return-on-Tangible-Equity compare to AHG and ACH?
According to the Medical Distribution industry distribution chart, Henry Schein ranks #1 out of 111 companies for Return-on-Tangible-Equity. This places Henry Schein in the top 1% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 8.81. Historically, Henry Schein's own Return-on-Tangible-Equity has ranged from 190.74 to 472.04 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 8.81, based on 111 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Henry Schein and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 8.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henry Schein's current Return-on-Tangible-Equity is Negative Tangible Equity%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henry Schein stock overvalued right now?
Based on GuruFocus' analysis, Henry Schein (HSIC) is currently considered Fairly Valued. The stock's GF Value™ is $83.72, compared to a current price of $86.43 — trading 3.2% above its estimated fair value. The current Return-on-Tangible-Equity is Negative Tangible Equity%. Henry Schein's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Henry Schein (HSIC), the current Return-on-Tangible-Equity is Negative Tangible Equity% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henry Schein (HSIC) Overvalued in 2026?
Based on GuruFocus' analysis, Henry Schein stock appears to be overvalued.
The current stock price of $86.43 is trading 3.2% above its estimated GF Value™ of $83.72.
GuruFocus considers Henry Schein to be Fairly Valued.
No single metric tells the full story. See the HSIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
80GF Score
Get the complete analysis for HSIC
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSIC has been successfully added to your 
